Drug Royalty Investment Trust

Drug Royalty Investment Trust is a other private fund operated by Dri Capital Inc. and has approximately $410.4 million in assets. There is currently no minimum investment for Drug Royalty Investment Trust . 0 percent of the fund is owned by fund of funds. Management has no ownership stake in the fund.

Drug Royalty Investment Trust Overview

Fund Type: other private  Drug Royalty Investment Trust is a other private fund

Private Fund ID: 805-3619881675 Drug Royalty Investment Trust has a private fund ID of 805-3619881675

Fund Manager: Dri Capital Inc. (Crd# 162943)

Registered Location: Delaware, United States

Total Assets: $410.4 million

Minimum Investment: $0

Drug Royalty Investment Trust Details

Subadviser: No Is Drug Royalty Investment Trust a subadviser

Other Investment Advisers: No other investment advisors

Solicited: No  Does Drug Royalty Investment Trust solicit investments?

Rely on Reg D Exemption: No  Does Drug Royalty Investment Trust have a Reg D exemption?

Audited: Yes  Does Drug Royalty Investment Trust shave audited financial statements?

Master Fund: Yes  Is Drug Royalty Investment Trust a master fund?

Feeder Fund: No  Is Drug Royalty Investment Trust a feeder fund?

GAAP: Yes  Does Drug Royalty Investment Trust use GAAP?

Beneficial Owners: 9  9 has 9 beneficial owners.

Management Ownership: 0% 

Fund of Fund Ownership: 10%  

Non-US Ownership: 23%  Non-US ownership in Drug Royalty Investment Trust

Auditor(s): Deloitte LLP

Broker-Dealer(s):

Custodian(s): Bank Of New York Mellon

Administrator(s):

Drug Royalty Investment Trust Charts and Graphs

Total AUM: $410.4 million

column_171} total assets are $410.4 million

Rank: 4094 out of 30967 registered private funds

Minimum Investment: $0

Drug Royalty Investment Trust has a minimum investment of $0.

Rank: 25527 out of 30967 registered private funds

Management Ownership: 0%

Drug Royalty Investment Trust is 0% owned by its management.

Rank: 21788 out of 30967 registered private funds